Zhongping Cheng Selected Research

Zhongping Cheng Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 07/2010
19	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 07/2010
9	Leiomyoma (Uterine Fibroids) 01/2015 - 02/2011
8	Adenomyosis 10/2021 - 03/2009
6	Neoplasm Metastasis (Metastasis) 03/2024 - 06/2010
6	Myoma 04/2022 - 05/2008
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 10/2020
3	Dysmenorrhea (Menstrual Pain) 10/2021 - 03/2009
3	Ovarian Epithelial Carcinoma 09/2018 - 06/2010
2	Primary Ovarian Insufficiency 11/2023 - 10/2023
2	Microsatellite Instability 01/2023 - 01/2022
2	Ascites 10/2022 - 07/2010
2	Ischemia 08/2022 - 03/2014
2	Hemorrhage 10/2021 - 08/2009
2	Hypoxia (Hypoxemia) 05/2014 - 03/2014
1	Inflammation (Inflammations) 03/2024
1	Insulin Resistance 03/2024
1	Glioma (Gliomas) 01/2023
1	Reperfusion Injury 08/2022
1	Infarction (Infarctions) 08/2022
1	Adenocarcinoma 01/2022
1	Intraoperative Complications 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Pain (Aches) 10/2021
1	Shock 10/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Postoperative Pain 07/2020
1	Pre-Eclampsia (Preeclampsia) 01/2020
1	Choriocarcinoma 01/2020
1	Amenorrhea 12/2019
1	Infertility (Sterility) 12/2019
1	Menorrhagia 12/2018

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2008
14	Messenger RNA (mRNA)IBA 10/2023 - 06/2013
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2019
5	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2015
4	Interleukin-8 (Interleukin 8)IBA 08/2023 - 01/2017
3	Long Noncoding RNAIBA 10/2023 - 09/2015
3	MicroRNAs (MicroRNA)IBA 10/2023 - 04/2022
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2019
3	AntigensIBA 01/2022 - 04/2019
3	BerberineIBA 07/2019 - 12/2017
2	olaparibIBA 03/2024 - 01/2022
2	CytokinesIBA 03/2024 - 01/2024
2	Small Cytoplasmic RNAIBA 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2022
2	MethyltransferasesIBA 01/2023 - 01/2022
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 06/2013
2	Therapeutic UsesIBA 05/2018 - 05/2014
2	LipopolysaccharidesIBA 12/2017 - 01/2015
2	matrigelIBA 05/2011 - 07/2010
1	LipidsIBA 03/2024
1	Chemokine ReceptorsIBA 03/2024
1	ChemokinesIBA 03/2024
1	Dasatinib (BMS 354825)FDA Link 03/2024
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	QuercetinIBA 03/2024
1	SenotherapeuticsIBA 03/2024
1	Carboplatin (JM8)FDA LinkGeneric 03/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Competitive Endogenous RNAIBA 10/2023
1	Immunoglobulins (Immunoglobulin)IBA 08/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 08/2023
1	CopperIBA 01/2023
1	Circular RNAIBA 10/2022
1	Protein Disulfide-IsomerasesIBA 10/2022
1	kaempferolIBA 08/2022
1	KinesinsIBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	CA-125 Antigen (CA 125 Antigen)IBA 02/2021
1	sinomenineIBA 01/2021
1	Tetracaine (Amethocaine)FDA LinkGeneric 07/2020
1	Propofol (Diprivan)FDA LinkGeneric 07/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	wogoninIBA 08/2019
1	FlavonoidsIBA 08/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2019
1	Complement System Proteins (Complement)IBA 04/2019
1	Macrophage Migration-Inhibitory FactorsIBA 04/2019
1	OsteopontinIBA 04/2019
1	AutoantibodiesIBA 04/2019
1	InterleukinsIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 12/2018

Therapy/Procedure

10	Therapeutics 03/2024 - 05/2014
6	Drug Therapy (Chemotherapy) 03/2024 - 07/2019
6	Hysterectomy 10/2021 - 03/2009
4	Immunotherapy 01/2023 - 01/2022
4	Uterine Myomectomy 04/2022 - 05/2008
3	Minimally Invasive Surgical Procedures 07/2023 - 01/2018
2	Laparotomy 01/2022 - 04/2021
2	Length of Stay 01/2022 - 04/2021
2	Nerve Block (Nerve Blocks) 10/2021 - 10/2019
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Uterine Artery Embolization 10/2021
1	Catheters 10/2021
1	Electrocoagulation (Electrocautery) 10/2021
1	Anesthesia 07/2020